Global Cannabinoid Derived Pharmaceutical Supply, Demand and Key Producers, 2023-2029
The global Cannabinoid Derived Pharmaceutical market size is expected to reach $ 1994.1 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).
This report studies the global Cannabinoid Derived Pharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cannabinoid Derived Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cannabinoid Derived Pharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cannabinoid Derived Pharmaceutical total production and demand, 2018-2029, (K Units)
Global Cannabinoid Derived Pharmaceutical total production value, 2018-2029, (USD Million)
Global Cannabinoid Derived Pharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cannabinoid Derived Pharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Cannabinoid Derived Pharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Cannabinoid Derived Pharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cara Therapeutics Inc, Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc, Echo Pharmaceuticals, Gw Pharmaceuticals, Inmed Pharmaceuticals, Insys Therapeutics Inc, Larapharm and Mgc Pharmaceuticals Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cannabinoid Derived Pharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cannabinoid Derived Pharmaceutical Market, By Region:
1. How big is the global Cannabinoid Derived Pharmaceutical market?
2. What is the demand of the global Cannabinoid Derived Pharmaceutical market?
3. What is the year over year growth of the global Cannabinoid Derived Pharmaceutical market?
4. What is the production and production value of the global Cannabinoid Derived Pharmaceutical market?
5. Who are the key producers in the global Cannabinoid Derived Pharmaceutical market?
6. What are the growth factors driving the market demand?
This report studies the global Cannabinoid Derived Pharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cannabinoid Derived Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cannabinoid Derived Pharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cannabinoid Derived Pharmaceutical total production and demand, 2018-2029, (K Units)
Global Cannabinoid Derived Pharmaceutical total production value, 2018-2029, (USD Million)
Global Cannabinoid Derived Pharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cannabinoid Derived Pharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Cannabinoid Derived Pharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cannabinoid Derived Pharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Cannabinoid Derived Pharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cara Therapeutics Inc, Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc, Echo Pharmaceuticals, Gw Pharmaceuticals, Inmed Pharmaceuticals, Insys Therapeutics Inc, Larapharm and Mgc Pharmaceuticals Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cannabinoid Derived Pharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cannabinoid Derived Pharmaceutical Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cannabinoid Receptor Type 1 (CB1)
- Cannabinoid Receptor Type 2 (CB2)
- Others
- Epilepsy
- Migraine
- Multiple Sclerosis
- Others
- Cara Therapeutics Inc
- Arena Pharmaceuticals
- Cannabics Pharmaceuticals Inc
- Echo Pharmaceuticals
- Gw Pharmaceuticals
- Inmed Pharmaceuticals
- Insys Therapeutics Inc
- Larapharm
- Mgc Pharmaceuticals Ltd
- One World Cannabis
- Orpheus Medica
- Receptor Life Sciences
- Respirerx Pharmaceuticals
- Tetra Bio-Pharma
- Cardiol Therapeutics
- United Cannabis Corporation
- Zynerba Pharmaceuticals
1. How big is the global Cannabinoid Derived Pharmaceutical market?
2. What is the demand of the global Cannabinoid Derived Pharmaceutical market?
3. What is the year over year growth of the global Cannabinoid Derived Pharmaceutical market?
4. What is the production and production value of the global Cannabinoid Derived Pharmaceutical market?
5. Who are the key producers in the global Cannabinoid Derived Pharmaceutical market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cannabinoid Derived Pharmaceutical Introduction
1.2 World Cannabinoid Derived Pharmaceutical Supply & Forecast
1.2.1 World Cannabinoid Derived Pharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.2.3 World Cannabinoid Derived Pharmaceutical Pricing Trends (2018-2029)
1.3 World Cannabinoid Derived Pharmaceutical Production by Region (Based on Production Site)
1.3.1 World Cannabinoid Derived Pharmaceutical Production Value by Region (2018-2029)
1.3.2 World Cannabinoid Derived Pharmaceutical Production by Region (2018-2029)
1.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.5 Europe Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.6 China Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.7 Japan Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cannabinoid Derived Pharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cannabinoid Derived Pharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cannabinoid Derived Pharmaceutical Demand (2018-2029)
2.2 World Cannabinoid Derived Pharmaceutical Consumption by Region
2.2.1 World Cannabinoid Derived Pharmaceutical Consumption by Region (2018-2023)
2.2.2 World Cannabinoid Derived Pharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.4 China Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.5 Europe Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.6 Japan Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.7 South Korea Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.8 ASEAN Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.9 India Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
3 WORLD CANNABINOID DERIVED PHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cannabinoid Derived Pharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Cannabinoid Derived Pharmaceutical Production by Manufacturer (2018-2023)
3.3 World Cannabinoid Derived Pharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Cannabinoid Derived Pharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cannabinoid Derived Pharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cannabinoid Derived Pharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Cannabinoid Derived Pharmaceutical in 2022
3.6 Cannabinoid Derived Pharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Cannabinoid Derived Pharmaceutical Market: Region Footprint
3.6.2 Cannabinoid Derived Pharmaceutical Market: Company Product Type Footprint
3.6.3 Cannabinoid Derived Pharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Comparison
4.1.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Comparison
4.2.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Comparison
4.3.1 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
4.5 China Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share
4.5.1 China Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
4.6 Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cannabinoid Derived Pharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cannabinoid Receptor Type 1 (CB1)
5.2.2 Cannabinoid Receptor Type 2 (CB2)
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cannabinoid Derived Pharmaceutical Production by Type (2018-2029)
5.3.2 World Cannabinoid Derived Pharmaceutical Production Value by Type (2018-2029)
5.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cannabinoid Derived Pharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Epilepsy
6.2.2 Migraine
6.2.3 Multiple Sclerosis
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Cannabinoid Derived Pharmaceutical Production by Application (2018-2029)
6.3.2 World Cannabinoid Derived Pharmaceutical Production Value by Application (2018-2029)
6.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cara Therapeutics Inc
7.1.1 Cara Therapeutics Inc Details
7.1.2 Cara Therapeutics Inc Major Business
7.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
7.1.4 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cara Therapeutics Inc Recent Developments/Updates
7.1.6 Cara Therapeutics Inc Competitive Strengths & Weaknesses
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Details
7.2.2 Arena Pharmaceuticals Major Business
7.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.2.4 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Arena Pharmaceuticals Recent Developments/Updates
7.2.6 Arena Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Cannabics Pharmaceuticals Inc
7.3.1 Cannabics Pharmaceuticals Inc Details
7.3.2 Cannabics Pharmaceuticals Inc Major Business
7.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product and Services
7.3.4 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cannabics Pharmaceuticals Inc Recent Developments/Updates
7.3.6 Cannabics Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.4 Echo Pharmaceuticals
7.4.1 Echo Pharmaceuticals Details
7.4.2 Echo Pharmaceuticals Major Business
7.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.4.4 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Echo Pharmaceuticals Recent Developments/Updates
7.4.6 Echo Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Gw Pharmaceuticals
7.5.1 Gw Pharmaceuticals Details
7.5.2 Gw Pharmaceuticals Major Business
7.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.5.4 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Gw Pharmaceuticals Recent Developments/Updates
7.5.6 Gw Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Inmed Pharmaceuticals
7.6.1 Inmed Pharmaceuticals Details
7.6.2 Inmed Pharmaceuticals Major Business
7.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.6.4 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Inmed Pharmaceuticals Recent Developments/Updates
7.6.6 Inmed Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Insys Therapeutics Inc
7.7.1 Insys Therapeutics Inc Details
7.7.2 Insys Therapeutics Inc Major Business
7.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
7.7.4 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Insys Therapeutics Inc Recent Developments/Updates
7.7.6 Insys Therapeutics Inc Competitive Strengths & Weaknesses
7.8 Larapharm
7.8.1 Larapharm Details
7.8.2 Larapharm Major Business
7.8.3 Larapharm Cannabinoid Derived Pharmaceutical Product and Services
7.8.4 Larapharm Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Larapharm Recent Developments/Updates
7.8.6 Larapharm Competitive Strengths & Weaknesses
7.9 Mgc Pharmaceuticals Ltd
7.9.1 Mgc Pharmaceuticals Ltd Details
7.9.2 Mgc Pharmaceuticals Ltd Major Business
7.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product and Services
7.9.4 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mgc Pharmaceuticals Ltd Recent Developments/Updates
7.9.6 Mgc Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.10 One World Cannabis
7.10.1 One World Cannabis Details
7.10.2 One World Cannabis Major Business
7.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Product and Services
7.10.4 One World Cannabis Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 One World Cannabis Recent Developments/Updates
7.10.6 One World Cannabis Competitive Strengths & Weaknesses
7.11 Orpheus Medica
7.11.1 Orpheus Medica Details
7.11.2 Orpheus Medica Major Business
7.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Product and Services
7.11.4 Orpheus Medica Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Orpheus Medica Recent Developments/Updates
7.11.6 Orpheus Medica Competitive Strengths & Weaknesses
7.12 Receptor Life Sciences
7.12.1 Receptor Life Sciences Details
7.12.2 Receptor Life Sciences Major Business
7.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product and Services
7.12.4 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Receptor Life Sciences Recent Developments/Updates
7.12.6 Receptor Life Sciences Competitive Strengths & Weaknesses
7.13 Respirerx Pharmaceuticals
7.13.1 Respirerx Pharmaceuticals Details
7.13.2 Respirerx Pharmaceuticals Major Business
7.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.13.4 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Respirerx Pharmaceuticals Recent Developments/Updates
7.13.6 Respirerx Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Tetra Bio-Pharma
7.14.1 Tetra Bio-Pharma Details
7.14.2 Tetra Bio-Pharma Major Business
7.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product and Services
7.14.4 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Tetra Bio-Pharma Recent Developments/Updates
7.14.6 Tetra Bio-Pharma Competitive Strengths & Weaknesses
7.15 Cardiol Therapeutics
7.15.1 Cardiol Therapeutics Details
7.15.2 Cardiol Therapeutics Major Business
7.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product and Services
7.15.4 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Cardiol Therapeutics Recent Developments/Updates
7.15.6 Cardiol Therapeutics Competitive Strengths & Weaknesses
7.16 United Cannabis Corporation
7.16.1 United Cannabis Corporation Details
7.16.2 United Cannabis Corporation Major Business
7.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product and Services
7.16.4 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 United Cannabis Corporation Recent Developments/Updates
7.16.6 United Cannabis Corporation Competitive Strengths & Weaknesses
7.17 Zynerba Pharmaceuticals
7.17.1 Zynerba Pharmaceuticals Details
7.17.2 Zynerba Pharmaceuticals Major Business
7.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.17.4 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Zynerba Pharmaceuticals Recent Developments/Updates
7.17.6 Zynerba Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cannabinoid Derived Pharmaceutical Industry Chain
8.2 Cannabinoid Derived Pharmaceutical Upstream Analysis
8.2.1 Cannabinoid Derived Pharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Cannabinoid Derived Pharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cannabinoid Derived Pharmaceutical Production Mode
8.6 Cannabinoid Derived Pharmaceutical Procurement Model
8.7 Cannabinoid Derived Pharmaceutical Industry Sales Model and Sales Channels
8.7.1 Cannabinoid Derived Pharmaceutical Sales Model
8.7.2 Cannabinoid Derived Pharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cannabinoid Derived Pharmaceutical Introduction
1.2 World Cannabinoid Derived Pharmaceutical Supply & Forecast
1.2.1 World Cannabinoid Derived Pharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.2.3 World Cannabinoid Derived Pharmaceutical Pricing Trends (2018-2029)
1.3 World Cannabinoid Derived Pharmaceutical Production by Region (Based on Production Site)
1.3.1 World Cannabinoid Derived Pharmaceutical Production Value by Region (2018-2029)
1.3.2 World Cannabinoid Derived Pharmaceutical Production by Region (2018-2029)
1.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.5 Europe Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.6 China Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.3.7 Japan Cannabinoid Derived Pharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cannabinoid Derived Pharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cannabinoid Derived Pharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cannabinoid Derived Pharmaceutical Demand (2018-2029)
2.2 World Cannabinoid Derived Pharmaceutical Consumption by Region
2.2.1 World Cannabinoid Derived Pharmaceutical Consumption by Region (2018-2023)
2.2.2 World Cannabinoid Derived Pharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.4 China Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.5 Europe Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.6 Japan Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.7 South Korea Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.8 ASEAN Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
2.9 India Cannabinoid Derived Pharmaceutical Consumption (2018-2029)
3 WORLD CANNABINOID DERIVED PHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cannabinoid Derived Pharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Cannabinoid Derived Pharmaceutical Production by Manufacturer (2018-2023)
3.3 World Cannabinoid Derived Pharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Cannabinoid Derived Pharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cannabinoid Derived Pharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cannabinoid Derived Pharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Cannabinoid Derived Pharmaceutical in 2022
3.6 Cannabinoid Derived Pharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Cannabinoid Derived Pharmaceutical Market: Region Footprint
3.6.2 Cannabinoid Derived Pharmaceutical Market: Company Product Type Footprint
3.6.3 Cannabinoid Derived Pharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Comparison
4.1.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Comparison
4.2.1 United States VS China: Cannabinoid Derived Pharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cannabinoid Derived Pharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Comparison
4.3.1 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cannabinoid Derived Pharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
4.5 China Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share
4.5.1 China Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
4.6 Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cannabinoid Derived Pharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cannabinoid Receptor Type 1 (CB1)
5.2.2 Cannabinoid Receptor Type 2 (CB2)
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cannabinoid Derived Pharmaceutical Production by Type (2018-2029)
5.3.2 World Cannabinoid Derived Pharmaceutical Production Value by Type (2018-2029)
5.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cannabinoid Derived Pharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Epilepsy
6.2.2 Migraine
6.2.3 Multiple Sclerosis
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Cannabinoid Derived Pharmaceutical Production by Application (2018-2029)
6.3.2 World Cannabinoid Derived Pharmaceutical Production Value by Application (2018-2029)
6.3.3 World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cara Therapeutics Inc
7.1.1 Cara Therapeutics Inc Details
7.1.2 Cara Therapeutics Inc Major Business
7.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
7.1.4 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cara Therapeutics Inc Recent Developments/Updates
7.1.6 Cara Therapeutics Inc Competitive Strengths & Weaknesses
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Details
7.2.2 Arena Pharmaceuticals Major Business
7.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.2.4 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Arena Pharmaceuticals Recent Developments/Updates
7.2.6 Arena Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Cannabics Pharmaceuticals Inc
7.3.1 Cannabics Pharmaceuticals Inc Details
7.3.2 Cannabics Pharmaceuticals Inc Major Business
7.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product and Services
7.3.4 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cannabics Pharmaceuticals Inc Recent Developments/Updates
7.3.6 Cannabics Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.4 Echo Pharmaceuticals
7.4.1 Echo Pharmaceuticals Details
7.4.2 Echo Pharmaceuticals Major Business
7.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.4.4 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Echo Pharmaceuticals Recent Developments/Updates
7.4.6 Echo Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Gw Pharmaceuticals
7.5.1 Gw Pharmaceuticals Details
7.5.2 Gw Pharmaceuticals Major Business
7.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.5.4 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Gw Pharmaceuticals Recent Developments/Updates
7.5.6 Gw Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Inmed Pharmaceuticals
7.6.1 Inmed Pharmaceuticals Details
7.6.2 Inmed Pharmaceuticals Major Business
7.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.6.4 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Inmed Pharmaceuticals Recent Developments/Updates
7.6.6 Inmed Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Insys Therapeutics Inc
7.7.1 Insys Therapeutics Inc Details
7.7.2 Insys Therapeutics Inc Major Business
7.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
7.7.4 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Insys Therapeutics Inc Recent Developments/Updates
7.7.6 Insys Therapeutics Inc Competitive Strengths & Weaknesses
7.8 Larapharm
7.8.1 Larapharm Details
7.8.2 Larapharm Major Business
7.8.3 Larapharm Cannabinoid Derived Pharmaceutical Product and Services
7.8.4 Larapharm Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Larapharm Recent Developments/Updates
7.8.6 Larapharm Competitive Strengths & Weaknesses
7.9 Mgc Pharmaceuticals Ltd
7.9.1 Mgc Pharmaceuticals Ltd Details
7.9.2 Mgc Pharmaceuticals Ltd Major Business
7.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product and Services
7.9.4 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mgc Pharmaceuticals Ltd Recent Developments/Updates
7.9.6 Mgc Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.10 One World Cannabis
7.10.1 One World Cannabis Details
7.10.2 One World Cannabis Major Business
7.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Product and Services
7.10.4 One World Cannabis Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 One World Cannabis Recent Developments/Updates
7.10.6 One World Cannabis Competitive Strengths & Weaknesses
7.11 Orpheus Medica
7.11.1 Orpheus Medica Details
7.11.2 Orpheus Medica Major Business
7.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Product and Services
7.11.4 Orpheus Medica Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Orpheus Medica Recent Developments/Updates
7.11.6 Orpheus Medica Competitive Strengths & Weaknesses
7.12 Receptor Life Sciences
7.12.1 Receptor Life Sciences Details
7.12.2 Receptor Life Sciences Major Business
7.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product and Services
7.12.4 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Receptor Life Sciences Recent Developments/Updates
7.12.6 Receptor Life Sciences Competitive Strengths & Weaknesses
7.13 Respirerx Pharmaceuticals
7.13.1 Respirerx Pharmaceuticals Details
7.13.2 Respirerx Pharmaceuticals Major Business
7.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.13.4 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Respirerx Pharmaceuticals Recent Developments/Updates
7.13.6 Respirerx Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Tetra Bio-Pharma
7.14.1 Tetra Bio-Pharma Details
7.14.2 Tetra Bio-Pharma Major Business
7.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product and Services
7.14.4 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Tetra Bio-Pharma Recent Developments/Updates
7.14.6 Tetra Bio-Pharma Competitive Strengths & Weaknesses
7.15 Cardiol Therapeutics
7.15.1 Cardiol Therapeutics Details
7.15.2 Cardiol Therapeutics Major Business
7.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product and Services
7.15.4 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Cardiol Therapeutics Recent Developments/Updates
7.15.6 Cardiol Therapeutics Competitive Strengths & Weaknesses
7.16 United Cannabis Corporation
7.16.1 United Cannabis Corporation Details
7.16.2 United Cannabis Corporation Major Business
7.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product and Services
7.16.4 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 United Cannabis Corporation Recent Developments/Updates
7.16.6 United Cannabis Corporation Competitive Strengths & Weaknesses
7.17 Zynerba Pharmaceuticals
7.17.1 Zynerba Pharmaceuticals Details
7.17.2 Zynerba Pharmaceuticals Major Business
7.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
7.17.4 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Zynerba Pharmaceuticals Recent Developments/Updates
7.17.6 Zynerba Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cannabinoid Derived Pharmaceutical Industry Chain
8.2 Cannabinoid Derived Pharmaceutical Upstream Analysis
8.2.1 Cannabinoid Derived Pharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Cannabinoid Derived Pharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cannabinoid Derived Pharmaceutical Production Mode
8.6 Cannabinoid Derived Pharmaceutical Procurement Model
8.7 Cannabinoid Derived Pharmaceutical Industry Sales Model and Sales Channels
8.7.1 Cannabinoid Derived Pharmaceutical Sales Model
8.7.2 Cannabinoid Derived Pharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cannabinoid Derived Pharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cannabinoid Derived Pharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cannabinoid Derived Pharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Cannabinoid Derived Pharmaceutical Production by Region (2018-2023) & (K Units)
Table 7. World Cannabinoid Derived Pharmaceutical Production by Region (2024-2029) & (K Units)
Table 8. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Cannabinoid Derived Pharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cannabinoid Derived Pharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cannabinoid Derived Pharmaceutical Major Market Trends
Table 13. World Cannabinoid Derived Pharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cannabinoid Derived Pharmaceutical Consumption by Region (2018-2023) & (K Units)
Table 15. World Cannabinoid Derived Pharmaceutical Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cannabinoid Derived Pharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cannabinoid Derived Pharmaceutical Producers in 2022
Table 18. World Cannabinoid Derived Pharmaceutical Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cannabinoid Derived Pharmaceutical Producers in 2022
Table 20. World Cannabinoid Derived Pharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cannabinoid Derived Pharmaceutical Company Evaluation Quadrant
Table 22. World Cannabinoid Derived Pharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cannabinoid Derived Pharmaceutical Production Site of Key Manufacturer
Table 24. Cannabinoid Derived Pharmaceutical Market: Company Product Type Footprint
Table 25. Cannabinoid Derived Pharmaceutical Market: Company Product Application Footprint
Table 26. Cannabinoid Derived Pharmaceutical Competitive Factors
Table 27. Cannabinoid Derived Pharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Cannabinoid Derived Pharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Cannabinoid Derived Pharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cannabinoid Derived Pharmaceutical Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cannabinoid Derived Pharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 37. China Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 47. World Cannabinoid Derived Pharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cannabinoid Derived Pharmaceutical Production by Type (2018-2023) & (K Units)
Table 49. World Cannabinoid Derived Pharmaceutical Production by Type (2024-2029) & (K Units)
Table 50. World Cannabinoid Derived Pharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cannabinoid Derived Pharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cannabinoid Derived Pharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cannabinoid Derived Pharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cannabinoid Derived Pharmaceutical Production by Application (2018-2023) & (K Units)
Table 56. World Cannabinoid Derived Pharmaceutical Production by Application (2024-2029) & (K Units)
Table 57. World Cannabinoid Derived Pharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cannabinoid Derived Pharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cannabinoid Derived Pharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cara Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 62. Cara Therapeutics Inc Major Business
Table 63. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 64. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cara Therapeutics Inc Recent Developments/Updates
Table 66. Cara Therapeutics Inc Competitive Strengths & Weaknesses
Table 67. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Arena Pharmaceuticals Major Business
Table 69. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 70. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Arena Pharmaceuticals Recent Developments/Updates
Table 72. Arena Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Cannabics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Cannabics Pharmaceuticals Inc Major Business
Table 75. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 76. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cannabics Pharmaceuticals Inc Recent Developments/Updates
Table 78. Cannabics Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 79. Echo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Echo Pharmaceuticals Major Business
Table 81. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 82. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Echo Pharmaceuticals Recent Developments/Updates
Table 84. Echo Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Gw Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Gw Pharmaceuticals Major Business
Table 87. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 88. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Gw Pharmaceuticals Recent Developments/Updates
Table 90. Gw Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Inmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Inmed Pharmaceuticals Major Business
Table 93. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 94. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Inmed Pharmaceuticals Recent Developments/Updates
Table 96. Inmed Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Insys Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 98. Insys Therapeutics Inc Major Business
Table 99. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 100. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Insys Therapeutics Inc Recent Developments/Updates
Table 102. Insys Therapeutics Inc Competitive Strengths & Weaknesses
Table 103. Larapharm Basic Information, Manufacturing Base and Competitors
Table 104. Larapharm Major Business
Table 105. Larapharm Cannabinoid Derived Pharmaceutical Product and Services
Table 106. Larapharm Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Larapharm Recent Developments/Updates
Table 108. Larapharm Competitive Strengths & Weaknesses
Table 109. Mgc Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Mgc Pharmaceuticals Ltd Major Business
Table 111. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product and Services
Table 112. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mgc Pharmaceuticals Ltd Recent Developments/Updates
Table 114. Mgc Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 115. One World Cannabis Basic Information, Manufacturing Base and Competitors
Table 116. One World Cannabis Major Business
Table 117. One World Cannabis Cannabinoid Derived Pharmaceutical Product and Services
Table 118. One World Cannabis Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. One World Cannabis Recent Developments/Updates
Table 120. One World Cannabis Competitive Strengths & Weaknesses
Table 121. Orpheus Medica Basic Information, Manufacturing Base and Competitors
Table 122. Orpheus Medica Major Business
Table 123. Orpheus Medica Cannabinoid Derived Pharmaceutical Product and Services
Table 124. Orpheus Medica Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Orpheus Medica Recent Developments/Updates
Table 126. Orpheus Medica Competitive Strengths & Weaknesses
Table 127. Receptor Life Sciences Basic Information, Manufacturing Base and Competitors
Table 128. Receptor Life Sciences Major Business
Table 129. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product and Services
Table 130. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Receptor Life Sciences Recent Developments/Updates
Table 132. Receptor Life Sciences Competitive Strengths & Weaknesses
Table 133. Respirerx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Respirerx Pharmaceuticals Major Business
Table 135. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 136. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Respirerx Pharmaceuticals Recent Developments/Updates
Table 138. Respirerx Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Tetra Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Tetra Bio-Pharma Major Business
Table 141. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product and Services
Table 142. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Tetra Bio-Pharma Recent Developments/Updates
Table 144. Tetra Bio-Pharma Competitive Strengths & Weaknesses
Table 145. Cardiol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 146. Cardiol Therapeutics Major Business
Table 147. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product and Services
Table 148. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Cardiol Therapeutics Recent Developments/Updates
Table 150. Cardiol Therapeutics Competitive Strengths & Weaknesses
Table 151. United Cannabis Corporation Basic Information, Manufacturing Base and Competitors
Table 152. United Cannabis Corporation Major Business
Table 153. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product and Services
Table 154. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. United Cannabis Corporation Recent Developments/Updates
Table 156. Zynerba Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 157. Zynerba Pharmaceuticals Major Business
Table 158. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 159. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Cannabinoid Derived Pharmaceutical Upstream (Raw Materials)
Table 161. Cannabinoid Derived Pharmaceutical Typical Customers
Table 162. Cannabinoid Derived Pharmaceutical Typical Distributors
Table 1. World Cannabinoid Derived Pharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cannabinoid Derived Pharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cannabinoid Derived Pharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Cannabinoid Derived Pharmaceutical Production by Region (2018-2023) & (K Units)
Table 7. World Cannabinoid Derived Pharmaceutical Production by Region (2024-2029) & (K Units)
Table 8. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Cannabinoid Derived Pharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cannabinoid Derived Pharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cannabinoid Derived Pharmaceutical Major Market Trends
Table 13. World Cannabinoid Derived Pharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cannabinoid Derived Pharmaceutical Consumption by Region (2018-2023) & (K Units)
Table 15. World Cannabinoid Derived Pharmaceutical Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cannabinoid Derived Pharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cannabinoid Derived Pharmaceutical Producers in 2022
Table 18. World Cannabinoid Derived Pharmaceutical Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cannabinoid Derived Pharmaceutical Producers in 2022
Table 20. World Cannabinoid Derived Pharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cannabinoid Derived Pharmaceutical Company Evaluation Quadrant
Table 22. World Cannabinoid Derived Pharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cannabinoid Derived Pharmaceutical Production Site of Key Manufacturer
Table 24. Cannabinoid Derived Pharmaceutical Market: Company Product Type Footprint
Table 25. Cannabinoid Derived Pharmaceutical Market: Company Product Application Footprint
Table 26. Cannabinoid Derived Pharmaceutical Competitive Factors
Table 27. Cannabinoid Derived Pharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Cannabinoid Derived Pharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Cannabinoid Derived Pharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cannabinoid Derived Pharmaceutical Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cannabinoid Derived Pharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 37. China Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Cannabinoid Derived Pharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share (2018-2023)
Table 47. World Cannabinoid Derived Pharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cannabinoid Derived Pharmaceutical Production by Type (2018-2023) & (K Units)
Table 49. World Cannabinoid Derived Pharmaceutical Production by Type (2024-2029) & (K Units)
Table 50. World Cannabinoid Derived Pharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cannabinoid Derived Pharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cannabinoid Derived Pharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cannabinoid Derived Pharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cannabinoid Derived Pharmaceutical Production by Application (2018-2023) & (K Units)
Table 56. World Cannabinoid Derived Pharmaceutical Production by Application (2024-2029) & (K Units)
Table 57. World Cannabinoid Derived Pharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cannabinoid Derived Pharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cannabinoid Derived Pharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cara Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 62. Cara Therapeutics Inc Major Business
Table 63. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 64. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cara Therapeutics Inc Recent Developments/Updates
Table 66. Cara Therapeutics Inc Competitive Strengths & Weaknesses
Table 67. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Arena Pharmaceuticals Major Business
Table 69. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 70. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Arena Pharmaceuticals Recent Developments/Updates
Table 72. Arena Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Cannabics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Cannabics Pharmaceuticals Inc Major Business
Table 75. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 76. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cannabics Pharmaceuticals Inc Recent Developments/Updates
Table 78. Cannabics Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 79. Echo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Echo Pharmaceuticals Major Business
Table 81. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 82. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Echo Pharmaceuticals Recent Developments/Updates
Table 84. Echo Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Gw Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Gw Pharmaceuticals Major Business
Table 87. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 88. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Gw Pharmaceuticals Recent Developments/Updates
Table 90. Gw Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Inmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Inmed Pharmaceuticals Major Business
Table 93. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 94. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Inmed Pharmaceuticals Recent Developments/Updates
Table 96. Inmed Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Insys Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 98. Insys Therapeutics Inc Major Business
Table 99. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product and Services
Table 100. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Insys Therapeutics Inc Recent Developments/Updates
Table 102. Insys Therapeutics Inc Competitive Strengths & Weaknesses
Table 103. Larapharm Basic Information, Manufacturing Base and Competitors
Table 104. Larapharm Major Business
Table 105. Larapharm Cannabinoid Derived Pharmaceutical Product and Services
Table 106. Larapharm Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Larapharm Recent Developments/Updates
Table 108. Larapharm Competitive Strengths & Weaknesses
Table 109. Mgc Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Mgc Pharmaceuticals Ltd Major Business
Table 111. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product and Services
Table 112. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mgc Pharmaceuticals Ltd Recent Developments/Updates
Table 114. Mgc Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 115. One World Cannabis Basic Information, Manufacturing Base and Competitors
Table 116. One World Cannabis Major Business
Table 117. One World Cannabis Cannabinoid Derived Pharmaceutical Product and Services
Table 118. One World Cannabis Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. One World Cannabis Recent Developments/Updates
Table 120. One World Cannabis Competitive Strengths & Weaknesses
Table 121. Orpheus Medica Basic Information, Manufacturing Base and Competitors
Table 122. Orpheus Medica Major Business
Table 123. Orpheus Medica Cannabinoid Derived Pharmaceutical Product and Services
Table 124. Orpheus Medica Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Orpheus Medica Recent Developments/Updates
Table 126. Orpheus Medica Competitive Strengths & Weaknesses
Table 127. Receptor Life Sciences Basic Information, Manufacturing Base and Competitors
Table 128. Receptor Life Sciences Major Business
Table 129. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product and Services
Table 130. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Receptor Life Sciences Recent Developments/Updates
Table 132. Receptor Life Sciences Competitive Strengths & Weaknesses
Table 133. Respirerx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Respirerx Pharmaceuticals Major Business
Table 135. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 136. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Respirerx Pharmaceuticals Recent Developments/Updates
Table 138. Respirerx Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Tetra Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Tetra Bio-Pharma Major Business
Table 141. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product and Services
Table 142. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Tetra Bio-Pharma Recent Developments/Updates
Table 144. Tetra Bio-Pharma Competitive Strengths & Weaknesses
Table 145. Cardiol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 146. Cardiol Therapeutics Major Business
Table 147. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product and Services
Table 148. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Cardiol Therapeutics Recent Developments/Updates
Table 150. Cardiol Therapeutics Competitive Strengths & Weaknesses
Table 151. United Cannabis Corporation Basic Information, Manufacturing Base and Competitors
Table 152. United Cannabis Corporation Major Business
Table 153. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product and Services
Table 154. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. United Cannabis Corporation Recent Developments/Updates
Table 156. Zynerba Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 157. Zynerba Pharmaceuticals Major Business
Table 158. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product and Services
Table 159. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Cannabinoid Derived Pharmaceutical Upstream (Raw Materials)
Table 161. Cannabinoid Derived Pharmaceutical Typical Customers
Table 162. Cannabinoid Derived Pharmaceutical Typical Distributors
LIST OF FIGURES
Figure 1. Cannabinoid Derived Pharmaceutical Picture
Figure 2. World Cannabinoid Derived Pharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cannabinoid Derived Pharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 5. World Cannabinoid Derived Pharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 9. Europe Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 10. China Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 11. Japan Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 12. Cannabinoid Derived Pharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 15. World Cannabinoid Derived Pharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 17. China Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 18. Europe Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 19. Japan Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 22. India Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cannabinoid Derived Pharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cannabinoid Derived Pharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cannabinoid Derived Pharmaceutical Markets in 2022
Figure 26. United States VS China: Cannabinoid Derived Pharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cannabinoid Derived Pharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cannabinoid Derived Pharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 32. World Cannabinoid Derived Pharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Type in 2022
Figure 34. Cannabinoid Receptor Type 1 (CB1)
Figure 35. Cannabinoid Receptor Type 2 (CB2)
Figure 36. Others
Figure 37. World Cannabinoid Derived Pharmaceutical Production Market Share by Type (2018-2029)
Figure 38. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Type (2018-2029)
Figure 39. World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Cannabinoid Derived Pharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Application in 2022
Figure 42. Epilepsy
Figure 43. Migraine
Figure 44. Multiple Sclerosis
Figure 45. Others
Figure 46. World Cannabinoid Derived Pharmaceutical Production Market Share by Application (2018-2029)
Figure 47. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Application (2018-2029)
Figure 48. World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Cannabinoid Derived Pharmaceutical Industry Chain
Figure 50. Cannabinoid Derived Pharmaceutical Procurement Model
Figure 51. Cannabinoid Derived Pharmaceutical Sales Model
Figure 52. Cannabinoid Derived Pharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Cannabinoid Derived Pharmaceutical Picture
Figure 2. World Cannabinoid Derived Pharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cannabinoid Derived Pharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 5. World Cannabinoid Derived Pharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Cannabinoid Derived Pharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 9. Europe Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 10. China Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 11. Japan Cannabinoid Derived Pharmaceutical Production (2018-2029) & (K Units)
Figure 12. Cannabinoid Derived Pharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 15. World Cannabinoid Derived Pharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 17. China Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 18. Europe Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 19. Japan Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 22. India Cannabinoid Derived Pharmaceutical Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cannabinoid Derived Pharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cannabinoid Derived Pharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cannabinoid Derived Pharmaceutical Markets in 2022
Figure 26. United States VS China: Cannabinoid Derived Pharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cannabinoid Derived Pharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cannabinoid Derived Pharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cannabinoid Derived Pharmaceutical Production Market Share 2022
Figure 32. World Cannabinoid Derived Pharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Type in 2022
Figure 34. Cannabinoid Receptor Type 1 (CB1)
Figure 35. Cannabinoid Receptor Type 2 (CB2)
Figure 36. Others
Figure 37. World Cannabinoid Derived Pharmaceutical Production Market Share by Type (2018-2029)
Figure 38. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Type (2018-2029)
Figure 39. World Cannabinoid Derived Pharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Cannabinoid Derived Pharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Application in 2022
Figure 42. Epilepsy
Figure 43. Migraine
Figure 44. Multiple Sclerosis
Figure 45. Others
Figure 46. World Cannabinoid Derived Pharmaceutical Production Market Share by Application (2018-2029)
Figure 47. World Cannabinoid Derived Pharmaceutical Production Value Market Share by Application (2018-2029)
Figure 48. World Cannabinoid Derived Pharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Cannabinoid Derived Pharmaceutical Industry Chain
Figure 50. Cannabinoid Derived Pharmaceutical Procurement Model
Figure 51. Cannabinoid Derived Pharmaceutical Sales Model
Figure 52. Cannabinoid Derived Pharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
